Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. | J Nanobiotechnology | 2023 | 36597108 | PubTator, text mining | PubMed |
| Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36596785 | PubTator, text mining | PubMed |
| Longitudinal proteomic profiling of the inflammatory response in dengue patients. | PLoS Negl Trop Dis | 2023 | 36595532 | PubTator, text mining | PubMed |
| IL-10-producing Th1 cells possess a distinct molecular signature in malaria | J Clin Invest | 2023 | 36594463 | PubTator, text mining | PubMed |
| Advanced T and Natural Killer Cell Therapy for Glioblastoma. | J Korean Neurosurg Soc | 2023 | 36588388 | PubTator, text mining | PubMed |
| Top advances of the year: Leukemia. | Cancer | 2023 | 36585394 | PubTator, text mining | PubMed |
| The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? | Blood Adv | 2023 | 36574293 | PubTator, text mining | PubMed |
| Moving towards biologically informed treatment strategies for T-cell lymphomas. | Int J Hematol | 2023 | 36574170 | PubTator, text mining | PubMed |
| Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients. | FEBS Open Bio | 2023 | 36560848 | PubTator, text mining | PubMed |
| Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. | J Allergy Clin Immunol | 2023 | 36522221 | PubTator, text mining | PubMed |
| Lessons learned from COVID-19 pandemic: Vaccine platform is a key player. | Process Biochem | 2023 | 36514356 | PubTator, text mining | PubMed |
| Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease. | Blood Adv | 2023 | 36508281 | PubTator, text mining | PubMed |
| Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. | Cancer Gene Ther | 2023 | 36494582 | PubTator, text mining | PubMed |
| Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines. | Strahlenther Onkol | 2023 | 36480032 | PubTator, text mining | PubMed |
| Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. | Cancer Med | 2023 | 36464889 | PubTator, text mining | PubMed |
| Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. | Nat Rev Cancer | 2023 | 36456755 | PubTator, text mining | PubMed |
| Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer. | Neoplasia | 2023 | 36413881 | PubTator, text mining | PubMed |
| Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies. | Transplantation | 2023 | 36413151 | PubTator, text mining | PubMed |
| Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment. | Cancer Sci | 2023 | 36394119 | PubTator, text mining | PubMed |
| The inflammatory proteome, obesity, and medical weight loss and regain in humans. | Obesity (Silver Spring) | 2023 | 36334095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=48